While enhanced expression of some RP genes has been reported in other human malignancies [66], including lung [28], colorectal [67], prostate [68] and RPL19 in breast cancer [69] this is the first report to define a functional role for RPL19 in the malignant phenotype. Here, RPL19 is linked to breast carcinoma.